BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 29699436)

  • 1. The association of different progesterone preparations with preterm birth prevention.
    Krispin E; Hadar E; Chen R; Wiznitzer A; Kaplan B
    J Matern Fetal Neonatal Med; 2019 Oct; 32(20):3452-3457. PubMed ID: 29699436
    [No Abstract]   [Full Text] [Related]  

  • 2. A randomised trial to compare 200 mg micronised progesterone effervescent vaginal tablet daily with 250 mg intramuscular 17 alpha hydroxy progesterone caproate weekly for prevention of recurrent preterm birth.
    Shambhavi S; Bagga R; Bansal P; Kalra J; Kumar P
    J Obstet Gynaecol; 2018 Aug; 38(6):800-806. PubMed ID: 29557230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaginal progesterone is as effective as cervical cerclage to prevent preterm birth in women with a singleton gestation, previous spontaneous preterm birth, and a short cervix: updated indirect comparison meta-analysis.
    Conde-Agudelo A; Romero R; Da Fonseca E; O'Brien JM; Cetingoz E; Creasy GW; Hassan SS; Erez O; Pacora P; Nicolaides KH
    Am J Obstet Gynecol; 2018 Jul; 219(1):10-25. PubMed ID: 29630885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervical cerclage for singleton pregnant patients on vaginal progesterone with progressive cervical shortening.
    Enakpene CA; DiGiovanni L; Jones TN; Marshalla M; Mastrogiannis D; Della Torre M
    Am J Obstet Gynecol; 2018 Oct; 219(4):397.e1-397.e10. PubMed ID: 30017683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does adjunctive use of progesterone in women with cerclage improve prevention of preterm birth?
    Sinkey RG; Garcia MR; Odibo AO
    J Matern Fetal Neonatal Med; 2018 Jan; 31(2):202-208. PubMed ID: 28068860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaginal progesterone decreases preterm birth ≤ 34 weeks of gestation in women with a singleton pregnancy and a short cervix: an updated meta-analysis including data from the OPPTIMUM study.
    Romero R; Nicolaides KH; Conde-Agudelo A; O'Brien JM; Cetingoz E; Da Fonseca E; Creasy GW; Hassan SS
    Ultrasound Obstet Gynecol; 2016 Sep; 48(3):308-17. PubMed ID: 27444208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaginal progesterone, oral progesterone, 17-OHPC, cerclage, and pessary for preventing preterm birth in at-risk singleton pregnancies: an updated systematic review and network meta-analysis.
    Jarde A; Lutsiv O; Beyene J; McDonald SD
    BJOG; 2019 Apr; 126(5):556-567. PubMed ID: 30480871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaginal progesterone decreases preterm birth and neonatal morbidity and mortality in women with a twin gestation and a short cervix: an updated meta-analysis of individual patient data.
    Romero R; Conde-Agudelo A; El-Refaie W; Rode L; Brizot ML; Cetingoz E; Serra V; Da Fonseca E; Abdelhafez MS; Tabor A; Perales A; Hassan SS; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Mar; 49(3):303-314. PubMed ID: 28067007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pessary or Progesterone to Prevent Preterm delivery in women with short cervical length: the Quadruple P randomised controlled trial.
    van Zijl MD; Koullali B; Naaktgeboren CA; Schuit E; Bekedam DJ; Moll E; Oudijk MA; van Baal WM; de Boer MA; Visser H; van Drongelen J; van de Made FW; Vollebregt KC; Muller MA; Bekker MN; Brons JTJ; Sueters M; Langenveld J; Franssen MT; Schuitemaker NW; van Beek E; Scheepers HCJ; de Boer K; Tepe EM; Huisjes AJM; Hooker AB; Verheijen ECJ; Papatsonis DN; Mol BWJ; Kazemier BM; Pajkrt E
    BMC Pregnancy Childbirth; 2017 Sep; 17(1):284. PubMed ID: 28870155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized controlled trial of intramuscular versus vaginal progesterone for the prevention of recurrent preterm birth.
    Elimian A; Smith K; Williams M; Knudtson E; Goodman JR; Escobedo MB
    Int J Gynaecol Obstet; 2016 Aug; 134(2):169-72. PubMed ID: 27168167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaginal progesterone combined with cervical pessary: A chance for pregnancies at risk for preterm birth?
    Stricker N; Timmesfeld N; Kyvernitakis I; Goerges J; Arabin B
    Am J Obstet Gynecol; 2016 Jun; 214(6):739.e1-739.e10. PubMed ID: 26692180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence of short cervix between 20 and 24 weeks of gestation and vaginal progesterone for prolonging of gestation.
    Maerdan M; Shi C; Zhang X; Fan L
    J Matern Fetal Neonatal Med; 2017 Jul; 30(14):1646-1649. PubMed ID: 27600865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of preterm birth with vaginal progesterone or 17-alpha-hydroxyprogesterone caproate: a critical examination of efficacy and safety.
    O'Brien JM; Lewis DF
    Am J Obstet Gynecol; 2016 Jan; 214(1):45-56. PubMed ID: 26558340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial.
    Hassan SS; Romero R; Vidyadhari D; Fusey S; Baxter JK; Khandelwal M; Vijayaraghavan J; Trivedi Y; Soma-Pillay P; Sambarey P; Dayal A; Potapov V; O'Brien J; Astakhov V; Yuzko O; Kinzler W; Dattel B; Sehdev H; Mazheika L; Manchulenko D; Gervasi MT; Sullivan L; Conde-Agudelo A; Phillips JA; Creasy GW;
    Ultrasound Obstet Gynecol; 2011 Jul; 38(1):18-31. PubMed ID: 21472815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cervical pessary plus vaginal progesterone versus long-term tocolysis for the prevention of preterm birth: An observational retrospective study.
    Tajima M; Yanazume S; Orita Y; Tazaki Y; Shinya M; Kobayashi H
    Int J Gynaecol Obstet; 2020 Aug; 150(2):206-212. PubMed ID: 32282943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Cervical Cerclage and Vaginal Progesterone in the Treatment of Cervical Incompetence with/without Preterm Birth History.
    Wang SW; Ma LL; Huang S; Liang L; Zhang JR
    Chin Med J (Engl); 2016 Nov; 129(22):2670-2675. PubMed ID: 27823998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaginal progesterone in women with twin gestations complicated by short cervix: a retrospective cohort study.
    Brubaker SG; Pessel C; Zork N; Gyamfi-Bannerman C; Ananth CV
    BJOG; 2015 Apr; 122(5):712-8. PubMed ID: 25428801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical outcomes and influence factors of 435 singleton pregnancies with short cervix].
    Zhu YC; Liu Y; Zhu SN; Liu YN; Liu MH; Chen J; Yang HX
    Zhonghua Fu Chan Ke Za Zhi; 2021 Feb; 56(2):89-95. PubMed ID: 33631879
    [No Abstract]   [Full Text] [Related]  

  • 19. Pessary Compared With Vaginal Progesterone for the Prevention of Preterm Birth in Women With Twin Pregnancies and Cervical Length Less Than 38 mm: A Randomized Controlled Trial.
    Dang VQ; Nguyen LK; Pham TD; He YTN; Vu KN; Phan MTN; Le TQ; Le CH; Vuong LN; Mol BW
    Obstet Gynecol; 2019 Mar; 133(3):459-467. PubMed ID: 30741812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaginal progesterone, cerclage or cervical pessary for preventing preterm birth in asymptomatic singleton pregnant women with a history of preterm birth and a sonographic short cervix.
    Alfirevic Z; Owen J; Carreras Moratonas E; Sharp AN; Szychowski JM; Goya M
    Ultrasound Obstet Gynecol; 2013 Feb; 41(2):146-51. PubMed ID: 22991337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.